ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628692 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628692; 2) Community: the network communities that were significantly associated with the response to NSC 628692; 3) Molecule: the relationships between components within communities and NSC 628692; 4) MDR: the compounds that were significantly associated with the NSC 628692.

NSC Compound Enrichment Correlation
NSC 749076 3-(7-methoxy-3-methyl-1,4-dioxy-quinoxalin-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0160549908501539 0.3180489
NSC 85701 Quinolinium, 6-ethoxy-2-[2-(8-hydroxy-5-quinolyl)vinyl]-1-methyl- iodide 0.0160549908501539 0.34113042
NSC 127755 Benzenesulfonyl fluoride, 3-chloro-4-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]butyl]-, monoethanesulfonate (9CI) 0.0185619722391416 0.18370796
NSC 328130 Null 0.0185619722391416 -0.14266218
NSC 363812 Tetraplatin 0.0185619722391416 0.06621816
NSC 38643 Lenamycin 0.0185619722391416 0.081694215
NSC 621335 Null 0.0185619722391416 0.17212224
NSC 628911 3-(2-N,N-diethylaminoethylamino)-7-nitro-1,2,4- benzotriazine 1,4-dioxide. Trifluoroacetate 0.0185619722391416 0.10670643
NSC 628915 3-(2-N,N-diethylaminoethylamino)-1,2,4-benzotriazine 1,4-dioxide. Hemihydrate 0.0185619722391416 0.11540614
NSC 652151 Null 0.0185619722391416 0.16016319
Total:64  Current:20    [First] [Prev] [Next] [Last]